Viewing Study NCT05007769


Ignite Creation Date: 2025-12-24 @ 11:07 PM
Ignite Modification Date: 2025-12-31 @ 2:07 AM
Study NCT ID: NCT05007769
Status: WITHDRAWN
Last Update Posted: 2021-11-05
First Post: 2021-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC
Sponsor: Washington University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module